Liquidia Corporation
NASDAQ:LQDABiotechnology
Healthcare
$56.63 +0.34%
+$0.23 today
- Market cap
- $5.10B
- Beta
- 0.59
- P/E (TTM)
- 271.8
- EPS (TTM)
- $0.25
52W Low $11.85High $73.22
Volume 1.34M
Average 1.50M
Income Statement
Follow revenue through to earnings.
Revenue
$158.32M
FY 2025 · Annual
+1031.2% YoYOperating Income
-$51.38M
FY 2025 · Annual
Net Income
-$68.92M
FY 2025 · Annual
Income Statement
USD
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 12.85M | 15.94M | 17.49M | 14M | 158.32M |
| Cost of Revenue | 3.02M | 2.86M | 2.89M | 5.88M | 13.24M |
| Gross Profit | 9.83M | 13.08M | 14.6M | 8.12M | 145.08M |
| Gross Margin | 76.5% | 82.1% | 83.5% | 58.0% | 91.6% |
| Research & Development | 20.52M | 19.44M | 43.24M | 47.84M | 39.28M |
| Selling, General & Admin | 23.11M | 32.41M | 44.74M | 81.57M | 157.18M |
| Operating Expenses | 43.63M | 51.85M | 87.98M | 129.41M | 196.45M |
| Depreciation & Amortization | 5.61M | 3.65M | 2.18M | 2.2M | 1.53M |
| EBITDA | (28.21M) | (35.03M) | (70.05M) | (115.71M) | (43.22M) |
| EBITDA Margin | -219.4% | -219.8% | -400.6% | -826.7% | -27.3% |
| Operating Income | (33.8M) | (38.77M) | (73.38M) | (121.29M) | (51.38M) |
| Operating Margin | -263.0% | -243.3% | -419.6% | -866.6% | -32.5% |
| Interest Income | 33K | 1.09M | 3.47M | 7.65M | 6.62M |
| Interest Expense | 762K | 2.34M | 6.27M | 12.49M | 24.17M |
| Other Income / Expenses | (782K) | (2.25M) | (5.12M) | (9.1M) | (17.55M) |
| Income Before Tax | (34.58M) | (41.02M) | (78.5M) | (130.39M) | (68.92M) |
| Pre-Tax Margin | -269.0% | -257.4% | -448.9% | -931.7% | -43.5% |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 |
| Net Income | (34.58M) | (41.02M) | (78.5M) | (130.39M) | (68.92M) |
| Net Margin | -269.0% | -257.4% | -448.9% | -931.7% | -43.5% |
| EPS (Basic) | (0.70) | (0.67) | (1.21) | (1.66) | (0.80) |
| EPS (Diluted) | (0.70) | (0.67) | (1.21) | (1.66) | (0.80) |
| 49.68M | 60.96M | 64.99M | 78.71M | 86.06M | |
| 49.68M | 60.96M | 64.99M | 78.71M | 86.06M |
LQDA Earnings Waterfall · TTM
NASDAQ:LQDA · Revenue to Net Income
Key Ratios
EPS$1.37
Gross Margin92.7%
Net Margin23.2%
P/E Ratio-12.2
P/S Ratio33.8
Analysis
$450.9M of revenue converted into $138.6M of net income for the selected period. Gross margin is 92.7% and net margin is 23.2%, showing how much revenue survives after costs and taxes. EPS is $1.37, tying the income statement back to per-share earnings.
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 8-K | Current report | Nov 10, 2026 | |
| 10-Q | Quarterly report | Nov 10, 2026 | |
| 4 | Statement of changes in beneficial ownership | Oct 28, 2026 | |
| 4 | Statement of changes in beneficial ownership | Oct 28, 2026 | |
| 8-K | Current report | Oct 14, 2026 |
How much revenue does LQDA generate?
Liquidia Corporation (LQDA) reported $158.32M of revenue in fiscal 2025.
Is LQDA profitable?
Liquidia Corporation (LQDA) reported -$68.92M of net income, with a net margin of -43.5%.
Continue the stock analysis
Jump to another research area for this company.